| Literature DB >> 30468715 |
Zhi Yang1, Yongqiang Zhao1, Guofu Lin1, Xiangyu Zhou1, Xiaofeng Jiang2, Haiying Zhao3.
Abstract
Noncoding RNA activated by DNA damage (NORAD) is a newly identified long non-coding RNA (lncRNA) comprising one exon located on Chr20q11.23. NORAD is unique among lncRNAs because it is highly conserved, abundantly expressed, upregulated upon DNA damage, and maintains chromosomal stability in human cells. NORAD is dysregulated in different types of cancers and has been implicated in several processes correlated with carcinogenesis, such as cell proliferation, invasion, metastasis, and apoptosis. The mechanisms underlying the effects of NORAD are complex and involve multiple factors and signaling pathways. The biologic function and mechanisms of NORAD in human cancers are systematically reviewed here to provide new directions for future research.Entities:
Keywords: Cancer; Genome stability; Long non-coding RNA; NORAD; Oncogene; Tumor suppressor
Mesh:
Substances:
Year: 2018 PMID: 30468715 DOI: 10.1016/j.cca.2018.11.025
Source DB: PubMed Journal: Clin Chim Acta ISSN: 0009-8981 Impact factor: 3.786